Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024
Vanda Pharmaceuticals (Nasdaq: VNDA) has announced it will release its third quarter 2024 financial results on Wednesday, November 6, 2024, after market close. The company will host a conference call at 4:30 PM ET the same day to discuss the financial results and corporate activities. The call will be accessible via phone and webcast through the company's website. A replay will be available from 8:30 PM ET on November 6 until November 13, 2024.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 mercoledì 6 novembre 2024, dopo la chiusura del mercato. L'azienda organizzerà una call di conferenza alle 16:30 ET nello stesso giorno per discutere i risultati finanziari e le attività aziendali. La chiamata sarà accessibile tramite telefono e webcast attraverso il sito web dell'azienda. Una registrazione sarà disponibile dalle 20:30 ET del 6 novembre fino al 13 novembre 2024.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el miércoles 6 de noviembre de 2024, después del cierre del mercado. La compañía realizará una conferencia telefónica a las 4:30 PM ET el mismo día para discutir los resultados financieros y las actividades corporativas. La llamada será accesible por teléfono y webcast a través del sitio web de la compañía. Una repetición estará disponible desde las 8:30 PM ET del 6 de noviembre hasta el 13 de noviembre de 2024.
반다 제약(Vanda Pharmaceuticals, Nasdaq: VNDA)은 2024년 11월 6일 수요일, 시장 종료 후에 2024년 3분기 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 4시 30분(ET)에 재무 결과 및 기업 활동에 대해 논의하는 컨퍼런스 콜을 개최할 예정입니다. 전화 및 웹 캐스트를 통해 회사 웹사이트에서 콜을 참여할 수 있습니다. 반복 청취는 11월 6일 오후 8시 30분(ET)부터 2024년 11월 13일까지 가능합니다.
Vanda Pharmaceuticals (Nasdaq: VNDA) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le mercredi 6 novembre 2024, après la fermeture des marchés. L'entreprise tiendra une conférence téléphonique à 16h30 (ET) le même jour pour discuter des résultats financiers et des activités de l'entreprise. L'appel sera accessible par téléphone et par webdiffusion via le site internet de l'entreprise. Un enregistrement sera disponible à partir de 20h30 (ET) le 6 novembre jusqu'au 13 novembre 2024.
Vanda Pharmaceuticals (Nasdaq: VNDA) hat bekannt gegeben, dass es seine Finanzergebnisse für das dritte Quartal 2024 am Mittwoch, den 6. November 2024, nach Börsenschluss veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz durchführen, um die Finanzergebnisse und Unternehmensaktivitäten zu besprechen. Der Anruf wird über Telefon und Webcast über die Website des Unternehmens zugänglich sein. Eine Wiederholung wird ab 20:30 Uhr ET am 6. November bis zum 13. November 2024 verfügbar sein.
- None.
- None.
Conference Call and Webcast to Follow
Vanda will host a conference call at 4:30 PM ET on Wednesday, November 6, 2024, during which management will discuss the third quarter 2024 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 2555000.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, November 6, 2024, beginning at 8:30 PM ET and will be accessible until Wednesday, November 13, 2024, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 2555000.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-third-quarter-2024-financial-results-on-november-6-2024-302291900.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When will Vanda Pharmaceuticals (VNDA) release Q3 2024 earnings?
What time is Vanda Pharmaceuticals (VNDA) Q3 2024 earnings call?
How can I access Vanda Pharmaceuticals (VNDA) Q3 2024 earnings call replay?
